The Swiss company SKAN – manufacturer of RABS & isolators and expert for system solutions in the cleanroom – was looking for a future-oriented air decontamination solution to integrate it into its own portfolio.
Even before COVID-19, it was clear to those responsible that this could only be a product which, in addition to filtering particles, would also be capable of destroying viruses without forming any by-products. The treatment of volatile organic compounds, such as toxic aldehydes, as well as the destruction of microorganisms, fungi or bacteria, was also an aspect that was desired from the potential new product to be marketed.
The choice fell on Calistair, whose air decontamination solutions all have the aforementioned attributes. In addition, the company offers a wide variety of models that SKAN customers in the health care and life science industries can select specifically according to their requirements to ensure the desired protection.
Customers from regulated environments worldwide benefit from Calistair technology, for which SKAN is now the distribution partner in Switzerland. This means that, for example, the production of pharmaceuticals will be even safer for the workforce in the future.
